DEITCHER STEVEN R 4
4 · Talon Therapeutics, Inc. · Filed Dec 23, 2010
Insider Transaction Report
Form 4
DEITCHER STEVEN R
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2010-12-21+1,635,000→ 1,635,000 totalExercise: $0.49Exp: 2020-12-21→ Common Stock (1,635,000 underlying)
Holdings
- 5,000
Common Stock
- 25,000
Stock Option (right to buy)
Exercise: $6.96Exp: 2017-08-24→ Common Stock (25,000 underlying) - 162,500
Stock Option (right to buy)
Exercise: $4.48Exp: 2017-12-14→ Common Stock (162,500 underlying) - 75,000
Stock Option (right to buy)
Exercise: $0.56Exp: 2019-02-24→ Common Stock (75,000 underlying) - 87,500
Stock Option (right to buy)
Exercise: $0.92Exp: 2020-06-07→ Common Stock (87,500 underlying) - 100,000
Stock Option (right to buy)
Exercise: $6.60Exp: 2017-05-21→ Common Stock (100,000 underlying) - 250,000
Stock Option (right to buy)
Exercise: $0.76Exp: 2020-02-16→ Common Stock (250,000 underlying)
Footnotes (6)
- [F1]On 9/10/10, the Company completed a one-for-four reverse stock split. All common stock amounts and exercise prices in the filing relating to securities acquired prior to 9/10/10 have been adjusted to reflect the one-for-four reverse stock split.
- [F2]100% vested
- [F3]25,000 shares vest on each of 2/24/10, 2/24/11 and 2/24/12.
- [F4]One-third of the shares vest on 2/16/11 and the remaining two-thirds vest in 24 equal monthly installments thereafter.
- [F5]One-third of the shares vest on 6/7/11 and the remaining two-thirds vest in 24 equal monthly installments thereafter.
- [F6]Shares vest in 48 equal monthly installments beginning 1/21/11.